GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qingdao Haier Biomedical Co Ltd (SHSE:688139) » Definitions » Research & Development

Qingdao Haier Biomedical Co (SHSE:688139) Research & Development : ¥318 Mil (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Qingdao Haier Biomedical Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Qingdao Haier Biomedical Co's Research & Development for the three months ended in Mar. 2024 was ¥77 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥318 Mil.


Qingdao Haier Biomedical Co Research & Development Historical Data

The historical data trend for Qingdao Haier Biomedical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Haier Biomedical Co Research & Development Chart

Qingdao Haier Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 121.36 150.72 236.31 292.47 320.64

Qingdao Haier Biomedical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.01 77.56 85.08 77.99 77.26

Qingdao Haier Biomedical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥318 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qingdao Haier Biomedical Co  (SHSE:688139) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Qingdao Haier Biomedical Co Research & Development Related Terms

Thank you for viewing the detailed overview of Qingdao Haier Biomedical Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Qingdao Haier Biomedical Co (SHSE:688139) Business Description

Traded in Other Exchanges
N/A
Address
No.1 Haier Road, Branding Building, Qingdao, CHN, 266101
Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.
Executives
Zhang Jiang Tao Core technical personnel
Liu Ji Yuan Core technical personnel
Teng Pei Kun Core technical personnel
Wang Guang Sheng senior management
Gong Yi Director
Huang Yan Li senior management
Chen Hai Tao Senior management, core technical personnel
Liu Zhan Jie Directors, senior managers, core technical personn
Mo Rui Juan senior management
Wang Wen Fu Director

Qingdao Haier Biomedical Co (SHSE:688139) Headlines

No Headlines